Insight

Immune checkpoint inhibitor-induced diarrhea and colitis – MASCC

Photo from Marianne Zoghbi/LinkedIn

Sep 25, 2024, 17:45

Immune checkpoint inhibitor-induced diarrhea and colitis – MASCC

The Multinational Association of Supportive Care in Cancer (MASCC) shared a post on LinkedIn about a recent paper by Marianne Zoghbi et al. published in Supportive Care in Cancer.

“Immune checkpoint inhibitor-induced diarrhea and colitis: an overview”

Authors: Marianne Zoghbi, Kathryn Burk, Elio Haroun, Maria Saade and Maria Teresa Cruz Carreras.

Immune checkpoint inhibitor-induced diarrhea and colitis - MASCC

“New open-access article in Supportive Care in Cancer: Immune checkpoint inhibitor-induced diarrhea and colitis: an overview.”

Source: MASCC/LinkedIn

Elio Haroun Kathryn Burk Maria Saade Maria Teresa Cruz Carreras Marianne Zoghbi MASCC Supportive Care in Cancer The Multinational Association of Supportive Care in Cancer

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer